Lessee, Operating Lease, Liability, to be Paid, Year Four of Omega Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Omega Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 31 Dec 2021 to 30 Sep 2024.
  • Omega Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Sep 2024 was $13,501,000.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Omega Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $13,501,000 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $13,065,000 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $12,895,000 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $12,549,000 31 Dec 2023 10-K 28 Mar 2024 2023 FY
Q4 2021 $10,879,000 31 Dec 2021 10-K 10 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.